About this trial
The primary objective of the current study is to examine the acute effect of lithium on the visual and non-visual responses to light in a sample of healthy participants. Our experiments will investigate the effects of lithium on light sensitivity at the level of the retina as well as central visual and non-visual pathways.
Our primary hypothesis is that the administration of lithium to healthy volunteers will reduce the magnitude of a range of non-visual responses to light including melatonin suppression, alertness, performance, mood and electrophysiology in a manner that is dependent of the amount of lithium in the brain. To better understand the postulated effects of lithium on light sensitivity and to examine its relationship at the level of the retina, we will assess the visual and non-visual responses to light, as well as the distribution of lithium in the brain using a non-invasive imaging technique. In addition to that, we also aim to examine the impact of both lithium and light on a molecular level through whole blood transcriptome sequencing.
Eligibility criteria
Qualifiers
Aged between 18 and 40 years old
Fluent in English (both spoken and written)
Sleep duration between 6.5 and 9 hours daily
Have a regular normal sleep schedule with bedtime (weekdays) between 21:30 and 01:00.
Disqualifiers
History of psychiatric or neurological disorders
First-degree family history of psychosis or severe mood disorder
Current or past suicidal ideation or self-harm
Current, chronic infections or diseases.
Trial design
Treatments tested in this trial
- Lithium carbonate (Priadel)
- Controlled light exposure
Treatment groups
Sponsors and collaborators
Northumbria University
Lead sponsor
Newcastle University
Collaborator
Northumberland, Tyne and Wear NHS Foundation Trust
Collaborator